BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang H, Yung MMH, Ngan HYS, Chan KKL, Chan DW. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression. Int J Mol Sci 2021;22:6560. [PMID: 34207286 DOI: 10.3390/ijms22126560] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Yan P, Li JW, Mo LG, Huang QR. A nomogram combining inflammatory markers and clinical factors predicts survival in patients with diffuse glioma. Medicine (Baltimore) 2021;100:e27972. [PMID: 34964788 DOI: 10.1097/MD.0000000000027972] [Reference Citation Analysis]
2 Ding X, Sun X, Cai H, Wu L, Liu Y, Zhao Y, Zhou D, Yu G, Zhou X. Engineering Macrophages via Nanotechnology and Genetic Manipulation for Cancer Therapy. Front Oncol 2021;11:786913. [PMID: 35070992 DOI: 10.3389/fonc.2021.786913] [Reference Citation Analysis]
3 Wang J, Jin J, Chen T, Zhou Q. Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages. Molecules 2022;27:4345. [DOI: 10.3390/molecules27144345] [Reference Citation Analysis]
4 Zeyn Y, Harms G, Tubbe I, Montermann E, Röhrig N, Hartmann M, Grabbe S, Bros M. Inhibitors of the Actin-Bundling Protein Fascin-1 Developed for Tumor Therapy Attenuate the T-Cell Stimulatory Properties of Dendritic Cells. Cancers (Basel) 2022;14:2738. [PMID: 35681718 DOI: 10.3390/cancers14112738] [Reference Citation Analysis]
5 Yung MMH, Siu MKY, Ngan HYS, Chan DW, Chan KKL. Orchestrated Action of AMPK Activation and Combined VEGF/PD-1 Blockade with Lipid Metabolic Tunning as Multi-Target Therapeutics against Ovarian Cancers. Int J Mol Sci 2022;23:6857. [PMID: 35743298 DOI: 10.3390/ijms23126857] [Reference Citation Analysis]
6 Xiao X, Li Y, Wang Y, Zhang Y, Chen J, Liu W, Tang J, Yue F, Yang J. Dihydroartemisinin inhibits Lewis Lung carcinoma progression by inducing macrophages M1 polarization via AKT/mTOR pathway. Int Immunopharmacol 2021;103:108427. [PMID: 34922249 DOI: 10.1016/j.intimp.2021.108427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Poznyak AV, Nikiforov NG, Starodubova AV, Popkova TV, Orekhov AN. Macrophages and Foam Cells: Brief Overview of Their Role, Linkage, and Targeting Potential in Atherosclerosis. Biomedicines 2021;9:1221. [PMID: 34572406 DOI: 10.3390/biomedicines9091221] [Reference Citation Analysis]
8 Liu C, Zhang X, Hu C, Liang X, Cao X, Wang D. Systematic Construction and Validation of a Novel Macrophage Differentiation–Associated Prognostic Model for Clear Cell Renal Cell Carcinoma. Front Genet 2022;13:877656. [DOI: 10.3389/fgene.2022.877656] [Reference Citation Analysis]
9 Schweer D, Mcatee A, Neupane K, Richards C, Ueland F, Kolesar J. Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy. Cancers 2022;14:2220. [DOI: 10.3390/cancers14092220] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Xing J, Chen M, Han Y. . MBE 2022;19:5905-24. [DOI: 10.3934/mbe.2022276] [Reference Citation Analysis]
11 Guo S, Chen X, Guo C, Wang W. Tumour-associated macrophages heterogeneity drives resistance to clinical therapy. Expert Rev Mol Med 2022;24:e17. [PMID: 35400355 DOI: 10.1017/erm.2022.8] [Reference Citation Analysis]
12 Liao KL, Watt KD. Mathematical Modeling and Analysis of CD200-CD200R in Cancer Treatment. Bull Math Biol 2022;84:82. [PMID: 35792958 DOI: 10.1007/s11538-022-01039-x] [Reference Citation Analysis]
13 Monteleone G, Maresca C, Colella M, Pacifico T, Congiu D, Troncone E, Marafini I. Targeting IL-34/MCSF-1R Axis in Colon Cancer. Front Immunol 2022;13:917955. [DOI: 10.3389/fimmu.2022.917955] [Reference Citation Analysis]
14 Pešut E, Đukić A, Lulić L, Skelin J, Šimić I, Milutin Gašperov N, Tomaić V, Sabol I, Grce M. Human Papillomaviruses-Associated Cancers: An Update of Current Knowledge. Viruses 2021;13:2234. [PMID: 34835040 DOI: 10.3390/v13112234] [Reference Citation Analysis]